FL S1364

Creates new criminal prohibition against knowingly using Schedule II controlled substances in a form or manner other than intended by manufacturer or prescriber, classified as first-degree misdemeanor (or third-degree felony on second offense).

Requires Board of Pharmacy to create and maintain a list of opioid analgesic drugs incorporating tamper-resistance technology that have been FDA-approved with human tampering/abuse studies.

Prohibits pharmacists from substituting opioid analgesic drugs for prescribed tamper-resistant opioid analgesics unless the substitute is listed as providing substantially similar tamper-resistance properties or prescriber provides written consent.

Updates cross-references in sections 893.055, 893.0551, and 921.0022 to reflect the new prohibited act and renumbering of existing violations.

Takes effect October 1, 2012.